Domenico Prezioso

Summary

Country: Italy

Publications

  1. ncbi Quality of life evaluation by the EORTC QLQ-C30 questionnaire in patients treated with hormonal treatment in Italy. A QuABIOS group study
    Domenico Prezioso
    Policlinico Universitario Federico II, Napoli, Italy
    Arch Ital Urol Androl 79:99-103. 2007
  2. ncbi Laboratory assessment
    Domenico Prezioso
    Department of Obstetrics, Gynecology and Urology, Federico II University, Naples, Italy
    Urol Int 79:20-5. 2007
  3. ncbi Actual chemotherapeutical possibilities in hormone-refractory prostate cancer (HRPC) patients
    Domenico Prezioso
    Department of Urology, Federico II University, Naples, Italy
    Anticancer Res 27:1095-104. 2007
  4. ncbi Role of surgery in treatment of locally advanced prostate cancer
    Domenico Prezioso
    Department of Urology Federico II University, Naples, Italy
    Anticancer Res 26:3151-8. 2006
  5. ncbi [Antibacterial prophylaxis in endourological procedures]
    D Prezioso
    Dipartimento Scienze Ginecologiche ed Urologiche, Universita degli Studi Federico II, Napoli, Italy
    Minerva Urol Nefrol 58:73-80. 2006
  6. ncbi Hormonal treatment for prostate cancer in Italy. Preliminary data from a survey of the QUABIOS Group
    Domenico Prezioso
    Policlinico Federico II, Napoli
    Arch Ital Urol Androl 78:15-9. 2006
  7. ncbi Gynecomastia due to hormone therapy for advanced prostate cancer: a report of ten surgically treated cases and a review of treatment options
    Domenico Prezioso
    Department of Urology, University of Naples Federico II, Italy
    Tumori 90:410-5. 2004
  8. ncbi Neoadjuvant hormone treatment with leuprolide acetate depot 3.75 mg and cyproterone acetate, before radical prostatectomy: a randomized study
    Domenico Prezioso
    Urology Clinic, University Federico II, Naples, Italy
    Urol Int 72:189-95. 2004
  9. ncbi Prevalence, incidence estimation, risk factors and characterization of chronic prostatitis/chronic pelvic pain syndrome in urological hospital outpatients in Italy: results of a multicenter case-control observational study
    Riccardo Bartoletti
    Department of Urology, University of Florence, Florence, Italy
    J Urol 178:2411-5; discussion 2415. 2007
  10. ncbi Testosterone deficiency causes penile fibrosis and organic erectile dysfunction in aging men. Evaluating association among Age, TDS and ED
    Fabrizio Iacono
    Department of Urology, University Federico II of Naples, Via Pansini 5, 80131 Naples, Italy
    BMC Surg 12:S24. 2012

Collaborators

Detail Information

Publications29

  1. ncbi Quality of life evaluation by the EORTC QLQ-C30 questionnaire in patients treated with hormonal treatment in Italy. A QuABIOS group study
    Domenico Prezioso
    Policlinico Universitario Federico II, Napoli, Italy
    Arch Ital Urol Androl 79:99-103. 2007
    ..We report here a prospective quality of life (QOL) evaluation over time and by hormonal treatment modalities...
  2. ncbi Laboratory assessment
    Domenico Prezioso
    Department of Obstetrics, Gynecology and Urology, Federico II University, Naples, Italy
    Urol Int 79:20-5. 2007
    ..The future for diagnosis, prevention and therapy will be the identification of genetic alterations and related specific dosage...
  3. ncbi Actual chemotherapeutical possibilities in hormone-refractory prostate cancer (HRPC) patients
    Domenico Prezioso
    Department of Urology, Federico II University, Naples, Italy
    Anticancer Res 27:1095-104. 2007
    ..There is also promising activity of new drug combinations, such as taxanes plus vinca alkaloids, and of classic chemotherapeutic agents plus biological drugs. This review focuses on the current therapies for the treatment of HRPC...
  4. ncbi Role of surgery in treatment of locally advanced prostate cancer
    Domenico Prezioso
    Department of Urology Federico II University, Naples, Italy
    Anticancer Res 26:3151-8. 2006
    ..The increased use of nomograms and increased knowledge of recognized prognostic factors could lead to the selection of a large number of patients, often with a long life expectancy, who could benefit from surgical treatment...
  5. ncbi [Antibacterial prophylaxis in endourological procedures]
    D Prezioso
    Dipartimento Scienze Ginecologiche ed Urologiche, Universita degli Studi Federico II, Napoli, Italy
    Minerva Urol Nefrol 58:73-80. 2006
    ..As Gram-negative strains are the most common pathogens, it is reasonable to use a quinolone or a beta-lactam...
  6. ncbi Hormonal treatment for prostate cancer in Italy. Preliminary data from a survey of the QUABIOS Group
    Domenico Prezioso
    Policlinico Federico II, Napoli
    Arch Ital Urol Androl 78:15-9. 2006
    ..We report here a summary of treatment schedules and related adverse effects, as recorded at the first visit...
  7. ncbi Gynecomastia due to hormone therapy for advanced prostate cancer: a report of ten surgically treated cases and a review of treatment options
    Domenico Prezioso
    Department of Urology, University of Naples Federico II, Italy
    Tumori 90:410-5. 2004
    ..In addition, we present a review of the various techniques used for the treatment of gynecomastia...
  8. ncbi Neoadjuvant hormone treatment with leuprolide acetate depot 3.75 mg and cyproterone acetate, before radical prostatectomy: a randomized study
    Domenico Prezioso
    Urology Clinic, University Federico II, Naples, Italy
    Urol Int 72:189-95. 2004
    ....
  9. ncbi Prevalence, incidence estimation, risk factors and characterization of chronic prostatitis/chronic pelvic pain syndrome in urological hospital outpatients in Italy: results of a multicenter case-control observational study
    Riccardo Bartoletti
    Department of Urology, University of Florence, Florence, Italy
    J Urol 178:2411-5; discussion 2415. 2007
    ..We evaluated the prevalence and estimated the incidence and risk factors of chronic prostatitis/chronic pelvic pain syndrome in urological hospital outpatients in Italy...
  10. ncbi Testosterone deficiency causes penile fibrosis and organic erectile dysfunction in aging men. Evaluating association among Age, TDS and ED
    Fabrizio Iacono
    Department of Urology, University Federico II of Naples, Via Pansini 5, 80131 Naples, Italy
    BMC Surg 12:S24. 2012
    ..We studied the possible correlation between age, testosterone deficiency, cavernosal fibrosis and erectile dysfunction (ED)...
  11. ncbi Cavernous body reduction in four patients with erectile dysfunction due to insufficient venous occlusion and a deficit of elastic fibers in the tunica albuginea
    Fabrizio Iacono
    Section of Urology, School of Medicine, University of Naples Federico II, Naples, Italy
    Int Braz J Urol 33:785-90; discussion 790-4. 2007
    ..We reasoned that if we decrease the corpus cavernosum radius, by excising a strip from each tunica albuginea, intracavernous pressure would increase during erection...
  12. ncbi Observational study: daily treatment with a new compound "Tradamixina" plus serenoa repens for two months improved the lower urinary tract symptoms
    Fabrizio Iacono
    Department of Urology, University Federico II of Naples, Via S, Pansini 5, 80131 Naples, Italy
    BMC Surg 12:S22. 2012
    ..This study seeks to evaluate the effect of a new natural compound "Tradamixina plus Serenoa Repens" in order to improve lower urinary tract symptoms...
  13. ncbi Sexual asthenia: Tradamixina versus Tadalafil 5 mg daily
    Fabrizio Iacono
    Department of Urology, University Federico II of Naples, Via S, Pansini 5, 80131 Naples, Italy
    BMC Surg 12:S23. 2012
    ....
  14. ncbi Tunical plication in the management of penile curvature due La Peyronie's disease. Our experience on 47 cases
    Fabrizio Iacono
    Department of Urology, University Federico II of Naples, Via Pansini 5, 80131 Naples, Italy
    BMC Surg 12:S25. 2012
    ..Our objective is to review the patient's sexual life after penile tunical plicature using the International Index of Erectile Function (IIEF) and the Sexual Encounter Profile (SEP) questionnaires...
  15. ncbi Efficacy and safety profile of a novel technique, ThuLEP (Thulium laser enucleation of the prostate) for the treatment of benign prostate hypertrophy. Our experience on 148 patients
    Fabrizio Iacono
    Department of Urology, School of Medicine, University Federico II of Naples, Via pasini 5, 80131 Naples, Italy
    BMC Surg 12:S21. 2012
    ....
  16. ncbi Overexpression of chromatin assembly factor-1 (CAF-1) p60 is predictive of adverse behaviour of prostatic cancer
    Stefania Staibano
    Department of Biomorphological and Functional Sciences, Pathology Section, University of Naples Federico II, Naples, Italy
    Histopathology 54:580-9. 2009
    ..The aim was to explore the role of CAF-1/p60 protein as a new prognostic marker for prostatic cancer...
  17. ncbi Prostate cancer treatment and quality of life
    Domenico Prezioso
    Department of Urology, University of Naples Federico II, Italy
    Recent Results Cancer Res 175:251-65. 2007
    ..The ultimate goal of QoL research should strongly improve medical care and concretely assist patients and physicians in treatment decision-making...
  18. ncbi Histopathologically proven prevention of post-prostatectomy cavernosal fibrosis with sildenafil
    Fabrizio Iacono
    Dipartimento di Ginecologia e Ostetricia, Medicina della Riproduzione e Urologia, Universita di Napoli Federico II, Naples, Italy
    Urol Int 80:249-52. 2008
    ..To evaluate whether a dose of 50 mg preserved the architecture of the corpora cavernosa biopsy in man...
  19. ncbi Tissue-resonance interaction method for the noninvasive diagnosis of prostate cancer: analysis of a multicentre clinical evaluation
    Luigi Da Pozzo
    Department of Urology, University Vita Salute H San Raffaele, Milan, Italy
    BJU Int 100:1055-9. 2007
    ....
  20. ncbi Introduction to chronic prostatitis and chronic pelvic pain syndrome (CP/CPPS)
    Riccardo Bartoletti
    Department of Urology, University of Florence, S Maria Annunziata Hospital, Italy
    Arch Ital Urol Androl 79:55-7. 2007
    ..001). CP/CPPS had a negative influence on sexual desire, erectile dysfunction and premature ejaculation (p < 0.001). The Meares Stamey test was positive in 13.3% of patients and 2.9% of controls...
  21. ncbi A case of giant cell tumor of the hipbone invading the bladder
    Fabrizio Iacono
    Department of Urology, University Federico II, Naples, Italy
    Urologia 78:142-4. 2011
    ..This is the first case in literature of GCTB of the hipbone invading the bladder...
  22. ncbi Estrogen receptor beta expression in human prostate tissue
    D Pasquali
    Istituto di Endocrinologia, , Via Pansini 5, 80131, Naples, Italy
    Mol Cell Endocrinol 178:47-50. 2001
    ..Nuclear ERbeta specific immunostaining was undetectable in all prostate cancer sections...
  23. ncbi Aims and methods. LUTS suggestive of BPH
    D Prezioso
    , Napoli, Italy
    Eur Urol 40:2-4. 2001
    ....
  24. ncbi Economic evaluation of different hormonal therapies for prostate cancer. Final results from the Quality of Life Antiandrogen Blockade Italian Observational Study (QuABIOS)
    Carlo Lazzaro
    A O SM Annunziata, Univ Firenze, Italy
    Arch Ital Urol Androl 79:104-7. 2007
    ....
  25. ncbi Estrogens and aspects of prostate disease
    Domenico Prezioso
    Oncology Center, Antwerpen, Belgium
    Int J Urol 14:1-16. 2007
    ..The present review considers this role in relation to the pathogenesis of prostate cancer and the potential cancer-repressive influence of the dietary estrogens...
  26. ncbi Italian validation of the urogenital distress inventory and its application in LUTS patients
    Walter Artibani
    University of Padua, Padua, Italy
    Eur Urol 50:1323-9. 2006
    ..01). CONCLUSIONS: The Italian version of the UDI is a valid and robust instrument, which can now be used reliably in daily practice and clinical research...
  27. ncbi Italian validation of the International Consultation on Incontinence Questionnaires
    Andrea Tubaro
    S. Andrea Hospital, Rome, Italy
    BJU Int 97:101-8. 2006
    ..38). CONCLUSION: The Italian version of both questionnaires is a valid and robust instrument which can now be used reliably both in daily practice and in clinical research...
  28. ncbi The prevention of prostate cancer
    Keith Griffiths
    Laurel Cottage, Castleton, Cardiff, UK
    Recent Results Cancer Res 175:33-63. 2007
    ..Since about 50% of all men worldwide, from both East and West, show evidence of microscopic cancer by 50 years of age, growth restraint would appear to be the pragmatic option to the possibility of preventing initiation...
  29. ncbi The endocrine-gland-derived vascular endothelial growth factor (EG-VEGF)/prokineticin 1 and 2 and receptor expression in human prostate: Up-regulation of EG-VEGF/prokineticin 1 with malignancy
    Daniela Pasquali
    Department of Clinical and Experimental Medicine and Surgery, Endocrine Unit, Second University of Napoli, Via Pansini 5, 80131 Napoli, Italy
    Endocrinology 147:4245-51. 2006
    ..Thus, the level of EG-VEGF/PK1 could be useful for prostate cancer outcome evaluation and as a target for prostate cancer treatment in the future...